A novel nanoproliposomes of lercanidipine: Development, in vitro and preclinical studies to support its effectiveness in hypertension therapy
-
Add time:09/02/2019 Source:sciencedirect.com
AimThe aim of the present study was to develop nanoproliposomes of lercanidipine, in order to overcome its poor biopharmaceutical properties and to improve its therapeutic efficacy in treating hypertension.
We also recommend Trading Suppliers and Manufacturers of Lercanidipine hydrochloride (cas 132866-11-6). Pls Click Website Link as below: cas 132866-11-6 suppliers
Prev:Research paperDevelopment of fast dissolving oral films containing lercanidipine HCl nanoparticles in semicrystalline polymeric matrix for enhanced dissolution and ex vivo permeation
Next:RNA binding protein PUM2 promotes the stemness of breast cancer cells via competitively binding to neuropilin-1 (NRP-1) mRNA with miR-376a) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Research paperDevelopment of fast dissolving oral films containing lercanidipine HCl nanoparticles in semicrystalline polymeric matrix for enhanced dissolution and ex vivo permeation09/01/2019
- Original ArticleDetermination of lercanidipine in human plasma by an improved UPLC–MS/MS method for a bioequivalence study☆08/31/2019
- Invited paperSubstituent effect of side chains on the photochemical behavior of a new generation 1,4-dihydropyridine: Lercanidipine08/30/2019
- pH-0064ependent gradient release microspheres of Lercanidipine hydrochloride (cas 132866-11-6): in vitro and in vivo evaluation08/29/2019
- Oral self emulsifying powder of Lercanidipine hydrochloride (cas 132866-11-6): Formulation and evaluation08/28/2019
- Research paperSolid self-emulsified nanostructures of Lercanidipine hydrochloride (cas 132866-11-6): A potential approach to improve the fraction of the dose absorbed08/27/2019
- Second generation lipid nanoparticles (NLC) as an oral drug carrier for delivery of Lercanidipine hydrochloride (cas 132866-11-6)08/26/2019
- Original ArticleApplication of planar chromatography for estimation of Lercanidipine hydrochloride (cas 132866-11-6) in dosage form08/25/2019
-
Health and Chemical more >